Efficacy of vitamin A supplementation for prevention and severity reduction of hand-foot-mouth disease in young childre
Phase 3
Not yet recruiting
- Conditions
- Hand-Foot-Mouth DiseaseHand,Foot and Mouth DiseaseEnterovirusVitamin Aclinical trials,randomized
- Registration Number
- TCTR20191002003
- Lead Sponsor
- ational Research Council of Thailand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 4000
Inclusion Criteria
1. Preschool children ages 1-6years attending participating childcare centers/kindergarten.
2. Parents or guardians consent to participate.
Exclusion Criteria
1. Taking vitamin A supplementation within one month prior to enrollement.
2. Known to be HIV-infected.
3. Having had Hand Foot Mouth Disease within one month prior to enrollement
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence and severity of Hand Foot Mouth Disease 1 year Incidence
- Secondary Outcome Measures
Name Time Method Size of outbreaks of HFMD in childcare centers/kindergartens in treatment versus control arms. 1 year Incidence of outbreak,Association of low serum vitamin A level and severity of HFMD in both arms 1 year Odds ratio
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does vitamin A modulate to reduce enterovirus-induced HFMD severity in children?
How does vitamin A supplementation compare to standard supportive care in preventing HFMD in Thai pediatric populations?
What biomarkers predict response to vitamin A in hand-foot-mouth disease prevention among young children?
What are the safety profiles of high-dose vitamin A in HFMD prevention for children under 5 years?
Are there synergistic effects of vitamin A with antiviral agents in managing enterovirus infections in pediatric patients?